Conference Coverage
Conference Coverage
New data on IV ketamine for resistant depression in the elderly
Overall, 48% of participants achieved a response, and 24% achieved remission of depressive symptoms following the first 4 weeks of twice-weekly...
Conference Coverage
Add-on antipsychotic beats switching meds in older adults with resistant depression
“These results are of great impact for clinicians managing older adults with treatment-resistant depression,” said Dr. Jennifer Gatchel.
Conference Coverage
Digital rectal exam fails as screening tool for prostate cancer
In a new study, 99% of digital rectal examinations did not raise suspicion for prostate cancer.
Conference Coverage
Urine test predicts future bladder cancer 12 years before symptoms
The test, if validated in further studies, has the potential to serve as a cancer screening tool for individuals at elevated risk for bladder...
Conference Coverage
Endurance exercise tied to more coronary atherosclerosis
Lifelong endurance athletes had more coronary plaques, including more noncalcified plaques, than fit and healthy individuals, according to a new...
Conference Coverage
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed but a survival benefit is observed.
Conference Coverage
Antipsychotic cuts Alzheimer’s-related agitation
Brexpiprazole will become the first drug to be approved for agitation in AD, doctor speculates.
Conference Coverage
‘Keto-like’ diet linked to doubling of heart disease risk
But one lipid expert has highlighted limitations of the observational study and advised caution in interpreting the results.
News
Even mild COVID is hard on the brain
New study results suggest a severe pattern of changes in how the brain communicates as well as its structure in people with anxiety and depression...
Conference Coverage
COORDINATEd effort boosts optimal therapy in patients with T2D and ASCVD